Sign in to continue:

Thursday, April 2nd, 2026

ValueMax Group Issues 40,000 New Shares Following Warrant Exercise at S$0.36 Each 1

Key Developments

  • Increase in Share Capital: ValueMax Group Limited has announced an increase in its issued ordinary shares from 940,023,259 (excluding 100,000 treasury shares) to 940,063,259 ordinary shares.
  • Issuance of New Shares via Warrant Exercise: The company allotted and issued 40,000 new ordinary shares as a result of the exercise of 40,000 warrants, each at an exercise price of S\$0.36 per share. The exercise took place on 11 December 2025.
  • Listing of New Shares: These newly issued shares will be listed and quoted on the Singapore Exchange Securities Trading Limited (SGX-ST) on 15 December 2025.
  • Outstanding Warrants: Following this exercise, there remain 7,742,050 outstanding warrants, each with an exercise price of S\$0.36, expiring at 5.00 p.m. on 14 September 2026.
  • Share Ranking: The new shares will rank pari passu (on equal footing) in all respects with the existing shares of the company.

Implications for Shareholders

  • Dilution Impact: The issuance of new shares will result in a marginal dilution of existing shareholders’ equity. However, the scale of the issuance (40,000 new shares versus a total of 940 million+ shares) means the impact is minimal.
  • Potential Upside from Warrant Exercises: With over 7.7 million outstanding warrants remaining, further exercises could provide the company with additional capital at S\$0.36 per share, potentially strengthening the balance sheet.
  • Possible Share Price Impact: The exercise price of S\$0.36 may act as a reference level for investors, especially if the market price approaches this level. The approaching expiry date of the outstanding warrants (14 September 2026) could also increase trading activity as holders decide whether to exercise.
  • Liquidity and Trading: The listing of new shares increases the float and could improve liquidity in the company’s shares on the SGX-ST.

Additional Details

  • Corporate Secretary: The announcement was made by Lotus Isabella Lim Mei Hua, Company Secretary, on 11 December 2025.
  • Warrant Details: Each outstanding warrant allows holders to subscribe for one new share at S\$0.36 before the expiry deadline.

Conclusion

While the current allotment is modest in scale and unlikely to materially affect the company’s capital structure, the presence of a significant number of outstanding warrants could lead to further capital inflows and changes in share capital over the coming months. Shareholders are advised to monitor future warrant exercises and any related announcements, as these could have implications for dilution, capital strength, and trading liquidity.


Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell shares of ValueMax Group Limited. Investors should conduct their own due diligence and consult professional advisers before making investment decisions.

View ValueMax W260914 Historical chart here



Livingstone Health Completes 20% Acquisition of Affinity Surgery Centre Pte. Ltd

Livingstone Health Holdings Completes Strategic Acquisition ...

Rex International Updates FY2024 Financial Loss Allocation: Key Revisions Explained

Rex International’s FY2024 Addendum: Reshuffled Loss Allocat...

   Ad